✦ LIBER ✦

No C1840 to T mutation in RYR1 in malignant hyperthermia

✍ Scribed by Julie L. Hall-Curran; Alistair D. Stewart; Sarah P. Ball; Jane P. Halsall; Philip M. Hopkins; F. Richard Ellis

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 76 KB
Volume: 2
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.1380020418

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in RYR1 in malignant hyperther

Mutations in RYR1 in malignant hyperthermia and central core disease

✍ Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

The RYR1 gene encodes the skeletal muscle isoform ryanodine receptor and is fundamental to the process of excitation-contraction coupling and skeletal muscle calcium homeostasis. Mapping to chromosome 19q13.2, the gene comprises 106 exons and encodes a protein of 5,038 amino acids. Mutations in the

Novel mutation in the RYR1 gene (R2454C)

Novel mutation in the RYR1 gene (R2454C) in a patient with malignant hyperthermia

✍ Martin Gencik; Alexandra Gencik; Wilhelm Mortier; Jörg T. Epplen 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 10 KB 👁 2 views

Identification of a novel mutation in th

Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia

✍ H. Rueffert; H. Kraus; D. Olthoff; C. Deutrich; U.G. Froster 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 18 KB 👁 1 views

A RYR1 mutation associated with recessiv

A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian families

✍ Danielle Carpenter; Azzam Ismail; Rachel L. Robinson; Christopher Ringrose; Patr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Frequency and localization of mutations

Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia

✍ Lucia Galli; Alfredo Orrico; Stefania Lorenzini; Stefano Censini; Michela Falcia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Malignant hyperthermia (MH) is a dominantly inherited pharmacogenetic condition that manifests as a life-threatening hypermetabolic reaction when a susceptible individual is exposed to common volatile anesthetics and depolarizing muscle relaxants. Although MH appears to be genetically heterogeneous,

RYR1 mutations causing central core dise

RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes

✍ Rachel L. Robinson; Collin Brooks; Sarah L. Brown; F. Richard Ellis; P. Jane Hal 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Malignant hyperthermia (MH) and central core disease (CCD) are autosomal dominant disorders of skeletal muscle. Susceptibility to MH is only apparent after exposure to volatile anesthetics and/or depolarizing muscle relaxants. CCD patients present with diffuse muscular weakness but are also at risk